Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood.

Enumeration of circulating tumor cells (CTCs) predicts overall survival and treatment response in metastatic cancer, but as many commercialized assays isolate CTCs positive for epithelial cell markers alone, CTCs with little or no epithelial cell adhesion molecule (EpCAM) expression stay undetected. Therefore, CTC enrichment and isolation by label-free methods based on biophysical rather than biochemical properties could provide a more representative spectrum of CTCs. Here, we report on a clinical-scale automated acoustic microfluidic platform processing 5 mL of erythrocyte-depleted paraformaldehyde (PFA)-fixed blood (diluted 1:2) at a flow rate of 75 μL/min, recovering 43/50 (86 ± 2.3%) breast cancer cell line cells (MCF7), with 0.11% cancer cell purity and 162-fold enrichment in close to 2 h based on intrinsic biophysical cell properties. Adjustments of the voltage settings aimed at higher cancer cell purity in the central outlet provided 0.72% cancer cell purity and 1445-fold enrichment that resulted in 62 ± 8.7% cancer cell recovery. Similar rates of cancer-cell recovery, cancer-cell purity, and fold-enrichment were seen with both prostate cancer (DU145, PC3) and breast cancer (MCF7) cell line cells. We identified eosinophil granulocytes as the predominant white blood cell (WBC) contaminant (85%) in the enriched cancer-cell fraction. Processing of viable cancer cells in erythrocyte-depleted blood provided slightly reduced results as to fixed cells (77% cancer cells in the enriched cancer cell fraction, with 0.2% WBC contamination). We demonstrate feasibility of enriching either PFA-fixed or viable cancer cells with a clinical-scale acoustic microfluidic platform that can be adjusted to meet requirements for either high cancer-cell recovery or higher purity and can process 5 mL blood samples in close to 2 h.

[1]  T. Huang,et al.  Acoustic separation of circulating tumor cells , 2015, Proceedings of the National Academy of Sciences.

[2]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[3]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[4]  Hongshen Ma,et al.  Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments. , 2014, Lab on a chip.

[5]  Chao Huang,et al.  A Microfluidic Platform for Precision Small-volume Sample Processing and Its Use to Size Separate Biological Particles with an Acoustic Microdevice , 2015, Journal of visualized experiments : JoVE.

[6]  M. Henry,et al.  Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? , 2011, Nature Reviews Urology.

[7]  Eugene J. Lim,et al.  Microfluidic, marker-free isolation of circulating tumor cells from blood samples , 2014, Nature Protocols.

[8]  S. Groshen,et al.  Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells , 2010, Clinical Cancer Research.

[9]  Nikolaus Schultz,et al.  Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. , 2014, European urology.

[10]  H. Bruus,et al.  Continuum modeling of hydrodynamic particle-particle interactions in microfluidic high-concentration suspensions. , 2016, Lab on a chip.

[11]  John Hines,et al.  Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System , 2015, PloS one.

[12]  Thomas Laurell,et al.  Carrier medium exchange through ultrasonic particle switching in microfluidic channels. , 2005, Analytical chemistry.

[13]  Caroline Dive,et al.  Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[15]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[16]  Thomas Laurell,et al.  Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells , 2013, PloS one.

[17]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[18]  P. Black,et al.  Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets. , 2016, Small.

[19]  Sridhar Ramaswamy,et al.  A microfluidic device for label-free, physical capture of circulating tumor cell-clusters , 2015, Nature Methods.

[20]  T. Laurell,et al.  Free flow acoustophoresis: microfluidic-based mode of particle and cell separation. , 2007, Analytical chemistry.

[21]  D. Heymann,et al.  Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. , 2016, Clinical chemistry.

[22]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[23]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[24]  Z. Brzózka,et al.  Acoustic radiation forces at liquid interfaces impact the performance of acoustophoresis. , 2014, Lab on a chip.

[25]  H. Jung,et al.  Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). , 2011, Lab on a chip.

[26]  Thomas Laurell,et al.  Efficient Removal of Platelets from Peripheral Blood Progenitor Cell Products Using a Novel Micro-Chip Based Acoustophoretic Platform , 2011, PloS one.

[27]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[28]  Herbert Shea,et al.  Acoustophoretic synchronization of mammalian cells in microchannels. , 2010, Analytical chemistry.

[29]  Kangfu Chen,et al.  Circulating Tumor Cell Isolation and Analysis. , 2016, Advances in clinical chemistry.

[30]  Martin Wiklund,et al.  Acoustofluidics 12: Biocompatibility and Cell Viability in Microfluidic Acoustic Resonators I Introduction Lab on a Chip , 2022 .

[31]  Joel Voldman,et al.  Iso-acoustic focusing of cells for size-insensitive acousto-mechanical phenotyping , 2016, Nature Communications.

[32]  Hongshen Ma,et al.  Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells , 2014, PloS one.

[33]  T. Laurell,et al.  Continuous flow microfluidic separation and processing of rare cells and bioparticles found in blood - A review. , 2017, Analytica chimica acta.

[34]  H. Lilja,et al.  Concurrent isolation of lymphocytes and granulocytes using prefocused free flow acoustophoresis. , 2015, Analytical chemistry.

[35]  Thomas Laurell,et al.  Acoustofluidic, label-free separation and simultaneous concentration of rare tumor cells from white blood cells. , 2015, Analytical chemistry.

[36]  H. Lilja,et al.  Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis. , 2012, Analytical chemistry.

[37]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[38]  T. Huang,et al.  Cell separation using tilted-angle standing surface acoustic waves , 2014, Proceedings of the National Academy of Sciences.

[39]  M R Speicher,et al.  The biology of circulating tumor cells , 2016, Oncogene.